ABSTRACT
Cognitive impairment is a common comorbidity of epilepsy, and adversely impacts people with both frontal lobe epilepsy (FLE) and temporal lobe epilepsy (TLE). While the underlying neural substrates in TLE have been extensively investigated, functional imaging studies in FLE are scarce. In this study, we profiled cognitive dysfunction in FLE, and directly compared FLE and TLE patients to establish commonalities and differences. We investigated 172 adult participants (56 with FLE, 64 with TLE, and 52 controls), using neuropsychological tests and four functional MRI tasks probing the neural correlates of expressive language (verbal fluency, verb generation) and working memory (verbal and visuo-spatial). Patient groups were comparable in disease duration and anti-epileptic drug load. We devised a multiscale approach to map the landscape of brain activation and deactivation during cognition, and track reorganization in FLE and TLE. Voxel-based analyses were complemented with profiling of task effects (i) across intrinsic functional systems, and (ii) along the principal functional connectivity gradient, which encodes a continuous transition from lower-level sensory to higher-order transmodal brain areas. We show that cognitive impairment in FLE is associated with reduced activation across attentional and executive systems, and reduced deactivation of the default mode system, indicative of a large-scale disorganization of task-related recruitment. Functional abnormalities in FLE were modulated by disease load. Patterns of dysfunction in FLE were broadly similar to those in TLE, but some traits were syndrome-specific: altered default-mode deactivation was more prominent in FLE, while impaired recruitment of posterior language areas during a task with semantic demands was more marked in TLE. Our study elucidates neural processes underlying language and working memory impairment in FLE, identifies shared and syndrome-specific alterations in the two most common focal epilepsies, and sheds light on system behavior that may be amenable to future remediation strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Participant recruitment was funded through the Wellcome Trust (Project Grants No 079474 and 083148 to MJK and JSD). We are grateful to the Epilepsy Society for supporting the Epilepsy Society MRI scanner. This research was also supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. LC acknowledges support from a Brain Research UK PhD scholarship (Award 14181), and from a Berkeley Fellowship jointly awarded by University College London and Gonville and Caius College, Cambridge. XH acknowledges grant support from the American Epilepsy Society. KT was supported by fellowships of the European Academy of Neurology and the Austrian Society of Neurology (OEGN). GPW was supported by the MRC (G0802012, MR/M00841X/1). LC, XH and DSB acknowledge support from the NINDS (R01-NS099348); DSB acknowledges support from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Paul Allen Family Foundation, and the ISI Foundation. BCB acknowledges research funding from the SickKids Foundation (NI17-039), the National Sciences and Engineering Research Council of Canada (NSERC; Discovery-1304413), CIHR (FDN-154298), Azrieli Center for Autism Research (ACAR), BrainCanada, the Montreal Neurological Institute, as well as Fonds de la recherche du Quebec-Sante' (FRQ-S) and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Written informed consent was obtained from all participants according to the standards of the Declaration of Helsinki. Participant recruitment was approved by the University College London Institute of Neurology and University College London Hospitals Research Ethics Committee.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data supporting the findings of this study are available from the corresponding authors upon reasonable request.
- ABBREVIATIONS
- ASM
- anti-seizure medication
- DMN
- default-mode network
- FCD
- focal cortical dysplasia
- FDA
- functional data analysis
- FDR
- false discovery rate
- FLE
- frontal lobe epilepsy
- fMRI
- functional magnetic resonance imaging
- FSL
- FMRIB Software Library
- FWE
- familywise error (rate)
- FWHM
- full width at half-maximum
- HCP
- Human Connectome Project
- LI
- laterality index
- MNI
- Montreal Neurological Institute
- NHNN
- National Hospital for Neurology and Neurosurgery
- ROI
- region of interest
- S(n)PM
- Statistical (non-) Parametric Mapping
- TLE
- temporal lobe epilepsy.
